Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest

scientific article published on June 2002

Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/THORAX.57.6.528
P932PMC publication ID1746351
P698PubMed publication ID12037229
P5875ResearchGate publication ID11335886

P2093author name stringGrassi V
Tantucci C
Franchini D
Boni E
Corda L
Pini L
Chiroli P
Damiani GP
P2860cites workA simple method to detect expiratory flow limitation during spontaneous breathingQ72257470
Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflationQ72604927
The effects of beta 2-agonists and caffeine on respiratory and limb muscle performanceQ72655894
Detection of expiratory flow limitation during mechanical ventilationQ72785308
Lung hyperinflation and flow limitation in chronic airway obstructionQ73161671
Detection of expiratory flow limitation during exercise in COPD patientsQ73165381
Quality of life changes in COPD patients treated with salmeterolQ73227906
Salmeterol reduces dyspnea and improves lung function in patients with COPDQ73614794
STATIC VOLUME-PRESSURE CHARACTERISTICS OF THE RESPIRATORY SYSTEM DURING MAXIMAL EFFORTSQ76951203
Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patientsQ77561357
Pulmonary mechanics. A unified analysis of the relationship between pressure, volume and gasflow in the lungs of normal and diseased human subjectsQ78842255
The interrelationships of pressure, flow, and volume during various respiratory maneuvers in normal and emphysematous subjectsQ78893228
Psychophysical bases of perceived exertionQ29615667
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory SocietyQ29616361
Breathlessness and exercise in patients with cardiorespiratory diseaseQ33472982
Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defectsQ36168525
Breathlessness in patients with chronic airflow limitation. Mechanisms and managementQ40700701
Acute bronchodilator trials in chronic obstructive pulmonary diseaseQ44654373
Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary diseaseQ46473735
Predicted values for clinical exercise testingQ49023950
Bronchodilator response in chronic obstructive pulmonary disease.Q50575120
Partitioning of work of breathing in mechanically ventilated COPD patients.Q51653641
The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables.Q52872563
"Intrinsic" positive end-expiratory pressure in stable patients with chronic obstructive pulmonary disease.Q54335721
Effects and mechanism of fenoterol on fatigued canine diaphragmQ69843992
Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway diseaseQ70047755
Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitationQ70210226
Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effectQ70244445
Force reserve of the diaphragm in patients with chronic obstructive pulmonary diseaseQ70445222
Pulmonary mechanics during exercise in subjects with chronic airflow obstructionQ70686088
Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary diseaseQ71906981
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectchronic obstructive pulmonary diseaseQ199804
P304page(s)528-532
P577publication date2002-06-01
P1433published inThoraxQ7796158
P1476titleVolume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest
P478volume57

Reverse relations

cites work (P2860)
Q37236604A pilot study of inspiratory capacity and resting dyspnea correlations in exacerbations of COPD and asthma
Q37808058An update on the use of indacaterol in patients with COPD.
Q51806623CPAP and EPAP elicit similar lung deflation in a non-equivalent mode in GOLD 3-4 COPD patients.
Q35564127Clinical dose-response relationship of fluticasone propionate in adults with asthma
Q80335131Comparison of oral and depot intra-muscular steroids in assessing steroid-responsiveness in COPD
Q55354971Dynamic hyperinflation during the 6-min walk test in severely asthmatic subjects.
Q35536935Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease
Q35536743Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD
Q37017336Hyperinflation and its management in COPD
Q35535545Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis
Q36738718Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients
Q37200994It's about time--directing our attention toward modifying the course of COPD.
Q36248482Methods for Assessing Expiratory Flow Limitation during Tidal Breathing in COPD Patients
Q36669434Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale
Q38066983New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients
Q46528034The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease
Q44631821Tidal expiratory flow limitation at rest as a functional marker of pulmonary emphysema in moderate-to-severe COPD.
Q84272121[Pharmacological treatment of hyperinflation]
Q80447701[Which definition to use when defining reversibility of airway obstruction?]

Search more.